Alx Oncology Holdings Inc is a biotechnology company focused on developing innovative therapies for patients suffering from cancer

The company specializes in creating novel immuno-oncology treatments that harness the power of the immune system to target and eliminate cancer cells. Through its proprietary platform, Alx Oncology aims to address significant unmet medical needs in oncology by advancing its drug candidates through clinical trials, striving to improve outcomes for patients with various types of malignancies. The company's research is driven by a commitment to scientific excellence and the goal of transforming cancer care.